Consensus Cloud Solutions (CCSI) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 revenue reached $88.5 million, up 1.5% year-over-year, driven by 8.2% growth in the Corporate segment and partially offset by a 9.5% decline in SoHo revenue.
Net income increased to $24.7 million, with EPS rising to $1.32 (basic) and $1.30 (diluted), reflecting operational improvements and share repurchases.
Adjusted EBITDA was $47.9 million with a 54.1% margin, and free cash flow grew 14% year-over-year to $38.5 million.
Corporate channel revenue hit $58.7 million, the highest since Q4 2022, with customer base growth and record net revenue retention.
Continued focus on secure SaaS solutions and AI-driven workflow enhancements for regulated industries.
Financial highlights
Adjusted net income rose 7.3% to $28.9 million; adjusted EPS increased 10.9% to $1.52.
Gross profit was $71.6 million with an 81% margin; operating income reached $37.7 million.
Cash and cash equivalents at quarter-end were $92.3 million; net cash from operating activities was $45.8 million.
Net debt to EBITDA ratio was 2.5x; total debt to EBITDA held steady at 3x.
Share repurchases totaled approximately 600,000 shares for $17 million in Q1 2026.
Outlook and guidance
Full-year 2026 revenue guidance reaffirmed at $350–$364 million; adjusted EBITDA $182–$193 million; adjusted EPS $5.55–$5.95.
Q2 2026 revenue projected at $87.9–$91.9 million; adjusted EBITDA $46.4–$49.6 million; adjusted EPS $1.43–$1.53.
Management expects free cash flow to approximate record 2025 levels and plans continued share repurchases.
Non-GAAP effective tax rate for 2026 expected between 19.7% and 21.7%.
Guidance excludes FX gains/losses on intercompany account revaluation.
Latest events from Consensus Cloud Solutions
- Board recommends approval of all four proposals, highlighting governance and ESG focus.CCSI
Proxy filing24 Apr 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and stock plan amendments.CCSI
Proxy filing24 Apr 2026 - Corporate growth, record cash flow, and buybacks drive strong results and positive 2026 outlook.CCSI
Q4 202511 Apr 2026 - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower revenue, with improved guidance for the year.CCSI
Q2 20241 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue fell 3.1% but margin gains and debt reduction supported strong corporate growth.CCSI
Q3 202415 Jan 2026 - Record free cash flow, margin strength, and debt reduction highlight 2024 performance.CCSI
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025